A phase I first-in-human trial to investigate PTI-125
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs PTI-125 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; First in man; Pharmacokinetics
- 09 Aug 2017 According to a Pain Therapeutics media release, the FDA has cleared the IND application for PTI-125.
- 02 Aug 2017 New trial record
- 31 Jul 2017 Results from this trial are expected by year-end 2017, according to a Pain Therapeutics media release.